Thursday, April 25, 2013

Miesha Tate vs Liz Carmouche added to July 27 UFC show

Liz Carmouche, Miesha Tate
Fox Sports announced last night that Miesha Tate vs Liz Carmouche has been added to UFC on Fox 8 July 27 at the Key Arena in Seattle. This will be the first women's match to appear on the main card of a UFC on Fox show. Julie Kedzie vs Germaine De Randamie will be on the prelims. Miesha vs Liz was first rumoured on Tuesday but many fans thought that Miesha was on a six month medical suspension after her recent loss to Cat Zingano. So I'm going to explain why she can fight because no one else will explain it. Yes, the Nevada State Athletic Commission announced that Miesha is on a six month medical suspension. For one thing, that is only for Nevada. It doesn't mean anything in Washington though in many cases, the UFC will have fighters sit out the length of the suspension anyway. A doctor can overrule the suspension. I guess it was assumed that Miesha broke her nose. But watching her over the years, she bleeds easily from the nose. It doesn't mean it's broken. Miesha wants to be on the Seattle show because she's from Tacoma. And for that reason, she's a draw there. Is she coming back too soon? Probably but the UFC wouldn't let her fight if she wasn't medically cleared. She is also stubborn which gets her into trouble sometimes. And that could happen against Liz Carmouche. Liz likes to come out aggressively and win early. But she has proven to be mistake prone and lose by submission. Miesha wins a lot of fights after her opponents make mistakes. I expect a good scrap. I know what you're thinking. If all it takes is a doctor's note to override a medical suspension, why do athletic commissions issue them in the first place? That would normally be a question for my buddy Zach Arnold at Fight Opinion. But I'll answer it. Athletic commissions are bureaucracies first and they do a lot of things just to show that they are doing something. Does anything a bureaucracy does make sense to anyone? You just answered your own question.

No comments:

Post a Comment